David Domzalski, CEO at Foamix Pharmaceuticals Ltd. (FOMX), sold 68 shares at $4.05 ($275) on 2018-12-03, disclosed to the SEC on 2018-12-06.
Open-market sale of $275 FOMX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FOMX | SELL | 2019-04-03 | $19K | — | Filing → |
| FOMX | SELL | 2018-11-20 | $20K | — | Filing → |
| FOMX | SELL | 2018-11-13 | $9K | — | Filing → |